VT News

Jamie Kompon

Ask VT AI
View News Summary
  • Vertex Pharmaceuticals reports mixed Q1 2025 results, with revenue rising but missing expectations, and faces intellectual property issues in Russia, but raises 2025 guidance and sees strong uptake for its new pain drug.
  • Trump signs order to boost U.S. drug production, streamlining approvals and increasing enforcement on foreign sites.
  • U.S. halts new research grants to Harvard amid compliance dispute over alleged violations and antisemitic incidents on campus.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Vertex Pharmaceuticals reports mixed Q1 2025 results, with revenue rising but missing expectations, and faces intellectual property issues in Russia, but raises 2025 guidance and sees strong uptake for its new pain drug.
  • Trump signs order to boost U.S. drug production, streamlining approvals and increasing enforcement on foreign sites.
  • U.S. halts new research grants to Harvard amid compliance dispute over alleged violations and antisemitic incidents on campus.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Jamie Kompon

Top Topics

Trending in U.S.

World

Sport